Ganeden Biotech Granted 100th Probiotic Patent
"The 100th patent approval is a true accomplishment for us, as it reflects the extent of our innovation and collaboration since the GanedenBC30 probiotic was first developed and patented just a little over a decade ago," said Sean Farmer, Chief Scientific Officer and co-founder of Ganeden Biotech.
Oct 19 2010 --- Ganeden Biotech, Inc., maker of the patented probiotic strain GanedenBC30, recently announced the granting of the company's 100th patent, which expands the use and scope of the GanedenBC30 probiotic to help improve digestive and immune health.
The 100th patent comes in the wake of Ganeden's latest collaboration with Organic Milling marking a milestone for the company as it continues to develop new product partnerships with some of the world's most innovative food and product manufacturers.
From Bigelow Tea and Red Mango to Guernsey Farms Dairy and Agostoni Chocolate, Ganeden's range of products and partnerships is a testament to the versatility and durability of their probiotic strain Bacillus coagulans GBI-30, 6086 branded as GanedenBC30, which has the unique ability to survive the harsh manufacturing process and still be activated in the body. This is attributed to the naturally occurring layer of organic material that protects the genetic core of the bacteria throughout the manufacturing and digestion process.
"The 100th patent approval is a true accomplishment for us, as it reflects the extent of our innovation and collaboration since the GanedenBC30 probiotic was first developed and patented just a little over a decade ago," said Sean Farmer, Chief Scientific Officer and co-founder of Ganeden Biotech. Farmer is credited with discovering the GanedenBC30 probiotic and has written each subsequent patent since helping co-found the company in 1997. "We owe our success to our unrivaled dedication to creativity and perseverance, inherent within each of our partnerships, which have enabled us to provide proven health benefits to millions of consumers via a variety of functional health products."
